glp 1 semaglutide side effects GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights GLP-1 Medications: What You Need

Rajgurus careful assessment of your goals, health, and medical history during your personal consultation will determine whether this therapy is right for you

3 min read The GLP-1 landscape changed on 1 April 2026, when the FDA approved Eli Lilly's orforglipron under the brand name Foundayo as the first non-peptide, small-molecule GLP-1 receptor agonist (GLP-1RA) anywhere in the world

There shall be instances where the desired results are not observed within the expected timeframe, necessitating patience or reconsideration of continued use

The brand also notes you may be able to cancel through your online account portal if that option is available

Non-negotiable for muscle preservation

Acetyl-L-carnitine seems to work best in people who have not had diabetes for a long time or who have poorly controlled type 2 diabetes